FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kendrith Rowland

Research Profile

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Debra L. Barton; Kelli Burger; Shaker R Dakhil; Tom R Fitch; Sadhna Kohli; Lisa A Kottschade; Daniel A Nikcevich; Paul J Novotny; Kendrith M Rowland; Jeff A Sloan; Gamini Soori; Mary Beth Wilwerding; Charles L Loprinzi
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9.
Kostandinos Sideras; Kendrith M Rowland; Jacob B Allred; Robert J Behrens; Amylou C Dueck; Tom R Fitch; Timothy J Hobday; Wilma L Lingle; Daniel A Nikcevich; Donald W Northfelt; Edith A Perez
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane.
Thanyanan Reungwetwattana; Nicholas F Reuter; Kendrith M Rowland; Steven E Schild; Katie Allen-Ziegler; Grace K Dy; James R Jett; Ronnie F Luyun; Sumithra J Mandrekar; Randolph S Marks; Julian R Molina; Alex A. Adjei
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kendrith Rowland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Debra L. Barton; Kelli Burger; Shaker R Dakhil; Tom R Fitch; Sadhna Kohli; Lisa A Kottschade; Daniel A Nikcevich; Paul J Novotny; Kendrith M Rowland; Jeff A Sloan; Gamini Soori; Mary Beth Wilwerding; Charles L Loprinzi
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2013;21(4):1185-92.
2012: Kostandinos Sideras; Kendrith M Rowland; Jacob B Allred; Robert J Behrens; Amylou C Dueck; Tom R Fitch; Timothy J Hobday; Wilma L Lingle; Daniel A Nikcevich; Donald W Northfelt; Edith A Perez
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane.
Clinical breast cancer 2012;12(6):387-91.
2012: Thanyanan Reungwetwattana; Nicholas F Reuter; Kendrith M Rowland; Steven E Schild; Katie Allen-Ziegler; Grace K Dy; James R Jett; Ronnie F Luyun; Sumithra J Mandrekar; Randolph S Marks; Julian R Molina; Alex A. Adjei
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(5):919-22.
2012: Maria C Pietanza; Katharine A Price; Gregory J Riely; Kendrith M Rowland; Ravi Salgia; Margaret Tonda; Michael S Wertheim; Christopher G Azzoli; Jan H Beumer; Afshin Dowlati; Shirish M Gadgeel; Mark G Kris; Lee M Krug; Thomas J Lynch; Vincent A Miller; Ben Mitchell; Naiyer A Rizvi
Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(5):856-65.
2011: Lisa A Kottschade; Alan R Berg; David B Johnson; Miroslaw A Mazurczak; Bronagh P Murphy; Kendrith M Rowland; Jeff A Sloan; Deanne A Smith; Philip J Stella; Charles L Loprinzi
The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(11):1769-77.
2011: Aminah Jatoi; John W Kugler; Charles L Loprinzi; Paul J Novotny; Kendrith M Rowland; Paul L Schaefer; Jeff A Sloan; Donald B Wender; Shaker R Dakhil; Howard M Gross
Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(10):1601-7.
2011: S John Weroha; Ann L Oberg; Katie L Allen Ziegler; Shaker R Dakhilm; Kendrith M Rowland; Lynn C Hartmann; Dennis F Moore; Gary L Keeney; Prema P Peethambaram; Paul Haluska
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma.
Gynecologic oncology 2011;122(1):116-20.
2011: Debra L. Barton; Edward J Wos; Rui Qin; Bassam I Mattar; Nathan Benjamin Green; Keith S Lanier; James Dewitt Bearden; John W Kugler; Kay L Hoff; Pavan S Reddy; Kendrith M Rowland; Mike Riepl; Bradley Christensen; Charles L Loprinzi
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(6):833-41.
2011: Heidi Mc Kean; Philip J Stella; Shauna L Hillman; Kendrith M Rowland; Michael W Cannon; Robert J Behrens; Gerald G Gross; Mark D Sborov; Eliot L Friedman; Aminah Jatoi
Exploring therapeutic decisions in elderly patients with non-small cell lung cancer: results and conclusions from North Central Cancer Treatment Group Study N0222.
Cancer investigation 2011;29(4):266-71.
2011: Debra L. Barton; Pamela J Atherton; Brent A Bauer; Dennis F Moore; Bassam I Mattar; Beth I Lavasseur; Kendrith M Rowland; Robin T Zon; Nguyet A Lelindqwister; Gauri G Nagargoje; Timothy I Morgenthaler; Jeff A Sloan; Charles L Loprinzi
The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).
The journal of supportive oncology 2011;9(1):24-31.
2011: David P Steensma; Jeff A Sloan; Shaker R Dakhil; Robert Dalton; Stephen P Kahanic; Diane J Prager; Philip J Stella; Kendrith M Rowland; Paul J Novotny; Charles L Loprinzi
Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(1):97-105.
2010: Grace K Dy; Shauna L Hillman; Kendrith M Rowland; Julian R Molina; Preston D Steen; Donald B Wender; Suresh Nair; Sumithra Mandrekar; Steven E Schild; Alex A Adjei
A front-line window of opportunity phase 2 study of sorafenib in patients with advanced nonsmall cell lung cancer: North Central Cancer Treatment Group Study N0326.
Cancer 2010;116(24):5686-93.
2010: Sherry L Wolf; Rui Qin; Smitha P Menon; Kendrith M Rowland; Sachdev Thomas; Robert Delaune; Diana Christian; Eduardo R Pajon; Daniel V Satele; Jeffrey L Berenberg; Charles L Loprinzi
Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(35):5182-7.
2010: Steven E Schild; Deepti Behl; Svetomir N Markovic; Paul D Brown; Jonathan R Sande; Richard L Deming; Kendrith M Rowland; James D Bearden
Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?
American journal of clinical oncology 2010;33(6):633-6.
2010: Carol M Moinpour; Nancy L Vaught; Bryan Goldman; Mary W Redman; Philip A Philip; Barbara Millwood; Scott M Lippman; Thomas E Seay; Patrick J Flynn; Eileen O'Reilly; Kendrith M Rowland; Ralph P Wong; Jacqueline K Benedetti; Charles D Blanke
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(22):3611-6.
2010: Philip A Philip; Jacqueline Benedetti; Christopher L Corless; Ralph Wong; Eileen O'Reilly; Patrick J Flynn; Kendrith M Rowland; James N Atkins; Barry C Mirtsching; Saul E Rivkin; Alok A Khorana; Bryan Goldman; Cecilia M Fenoglio-Preiser; James L Abbruzzese; Charles D Blanke
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(22):3605-10.
2010: Alan H Bryce; Bassam Mattar; Shauna Hillman; Alex A Adjei; John W Kugler; Kendrith M Rowland; Donald B Wender; Gamini Soori; Edith A Perez; James R Jett
Phase II trial of oral topotecan and intravenous carboplatin with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: A North Central Cancer Treatment Group Study.
American journal of clinical oncology 2010;33(4):353-7.
2010: Cheng E Chee; James R Jett; Albert M Bernath; Nathan R Foster; Garth D Nelson; Julian Molina; Daniel A Nikcevich; Preston D Steen; Patrick J Flynn; Kendrith M Rowland
Phase 2 trial of pemetrexed disodium and carboplatin in previously untreated extensive-stage small cell lung cancer, N0423.
Cancer 2010;116(10):2382-9.
2010: Amanda R Moraska; Pamela J Atherton; Daniel W Szydlo; Debra L. Barton; Philip J Stella; Kendrith M Rowland; Paul L Schaefer; James Krook; James D Bearden; Charles L Loprinzi
Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.
The journal of supportive oncology 2010;8(3):128-32.
2010: Antonio C Wolff; Molin Wang; Hailun Li; Michael R Pins; Florence J Pretorius; Kendrith M Rowland; Joseph A Sparano; Nancy E Davidson
Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group trial E3198.
Breast cancer research and treatment 2010;121(1):111-20.
2010: Maurie Markman; James Moon; Sharon Wilczynski; Ana Maria Lopez; Kendrith M Rowland; David P Michelin; Victor J Lanzotti; Garnet L Anderson; David S Alberts
Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial.
Gynecologic oncology 2010;116(3):323-5.
2010: Ann E Kearns; Donald W Northfelt; Amylou Dueck; Pamela J Atherton; Shaker R Dakhil; Kendrith M Rowland; Jyotsna Fuloria; Patrick J Flynn; Todor Dentchev; Charles L Loprinzi
Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2010;18(3):321-8.
2010: Charles L Loprinzi; Rui Qin; Ernie P Balcueva; Ernie P Baclueva; Kathleen A Flynn; Kendrith M Rowland; David Graham; Nancy K Erwin; Shaker R Dakhil; Donald J Jurgens; Kelli N Burger
Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):641-7.
2010: Alex A Adjei; Sumithra J Mandrekar; Grace K Dy; Julian R Molina; Araba A Adjei; David R Gandara; Katie L Allen Ziegler; Philip J Stella; Kendrith M Rowland; Steven E Schild; Ralph G Zinner
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):614-9.
2010: Sumithra J Mandrekar; Yingwei Qi; Shauna L Hillman; Katie L Allen Ziegler; Nicholas F Reuter; Kendrith M Rowland; Steven A Kuross; Randolph S Marks; Steven E Schild; Alex A. Adjei
Endpoints in phase II trials for advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(1):3-9.
2009: Freddy Nguyen; Adam M Zysk; Eric J Chaney; Jan G. Kotynek; Uretz J. Oliphant; Frank J Bellafiore; Kendrith M Rowland; Patricia A. Johnson; Allen Stephen Boppart
Intraoperative evaluation of breast tumor margins with optical coherence tomography.
Cancer research 2009;69(22):8790-6.
2009: Yingwei Qi; Steven E Schild; Sumithra J Mandrekar; Angelina D Tan; James E Krook; Kendrith M Rowland; Yolanda I Garces; Gamini S Soori; Alex A. Adjei; Jeff A Sloan
Pretreatment quality of life is an independent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(9):1075-82.
2009: Nathan R Foster; Sumithra J Mandrekar; Steven E Schild; Garth D Nelson; Kendrith M Rowland; Richard L Deming; Timothy F Kozelsky; Randolph S Marks; James R Jett; Alex A. Adjei
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
Cancer 2009;115(12):2721-31.
2009: George P Kim; Daniel J Sargent; Michelle R Mahoney; Kendrith M Rowland; Philip A Philip; Edith Mitchell; Abraham P Mathews; Tom R Fitch; Richard M Goldberg; Steven R Alberts; Henry C Pitot
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(17):2848-54.
2009: Charles L Loprinzi; A C Dueck; B S Khoyratty; Debra L. Barton; S Jafar; Kendrith M Rowland; Pamela J Atherton; G W Marsa; W H Knutson; James Bearden; L Kottschade; Tom R Fitch
A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(3):542-9.
2009: Aminah Jatoi; Shauna Hillman; Katie L Allen Ziegler; Philip J Stella; Gamini S Soori; Kendrith M Rowland
Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222.
Cancer management and research 2009;1():61-8.
2009: Aminah Jatoi; Erin M Green; Kendrith M Rowland; Daniel J Sargent; Steven R Alberts
Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147.
Oncology 2009;77(2):120-3.
2009: Alvaro Moreno-Aspitia; Roscoe F Morton; David W Hillman; Wilma L Lingle; Kendrith M Rowland; Martin Wiesenfeld; Patrick J Flynn; Tom R Fitch; Edith A Perez
Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):11-5.
2008: Svetomir N Markovic; Vera J Suman; Wendy K Nevala; Louis Geeraerts; Edward T. Creagan; Lori A Erickson; Kendrith M Rowland; Roscoe F Morton; William L Horvath; Mark R Pittelkow
A dose-escalation study of aerosolized sargramostim in the treatment of metastatic melanoma: an NCCTG Study.
American journal of clinical oncology 2008;31(6):573-9.
2008: Paul D. Brown; Sunil Krishnan; Jann N. Sarkaria; Wenting Wu; Kurt A Jaeckle; Joon H Uhm; Francois J Geoffroy; Robert M Arusell; Gaspar Kitange; Robert B Jenkins; John W Kugler; Roscoe F Morton; Kendrith M Rowland; Paul Mischel; William H Yong; Bernd W Scheithauer; David Schiff; Caterina Giannini; Jan C Buckner
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5603-9.
2008: Aminah Jatoi; Kendrith M Rowland; Jeff A Sloan; Howard M Gross; Paul A. Fishkin; Stephen P Kahanic; Paul J Novotny; Paul L Schaefer; David B Johnson; Loren K Tschetter; Charles L Loprinzi
Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB).
Cancer 2008;113(4):847-53.
2008: Stephen M Ansell; David J Inwards; Kendrith M Rowland; Patrick J Flynn; Roscoe F Morton; Dennis F Moore; Scott H Kaufmann; Irene M Ghobrial; Paul J Kurtin; Matthew Maurer; Cristine Allmer; Thomas E Witzig
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group.
Cancer 2008;113(3):508-14.
2008: Aminah Jatoi; Shaker R Dakhil; Nathan R Foster; Cynthia Ma; Kendrith M Rowland; Dennis F Moore; Anthony J Jaslowski; Sachdev P Thomas; Mark D Hauge; Patrick J Flynn; Philip J Stella; Steven R Alberts
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(5):516-20.
2008: Scott H Okuno; Robert Delaune; Jeff A Sloan; Nathan R Foster; Matthew J Maurer; Marie-Christine Aubry; Kendrith M Rowland; Gamini S Soori; Daniel A Nikcevich; Carl G Kardinal; Donald W Northfelt; Alex A. Adjei
A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.
Cancer 2008;112(8):1772-9.
2007: Aminah Jatoi; Shaker R Dakhil; Phuong L Nguyen; Jeff A Sloan; John W Kugler; Kendrith M Rowland; Gamini S Soori; Donald B Wender; Tom R Fitch; Paul J Novotny; Charles L Loprinzi
A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
Cancer 2007;110(6):1396-403.
2007: David M Kurtz; Loren K Tschetter; Jacob B Allred; Susan M Geyer; Paul J Kurtin; Wesley D Putnam; Kendrith M Rowland; Martin Wiesenfeld; Gamini S Soori; Richard C Tenglin; Albert M Bernath; Thomas E Witzig
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.
Leukemia & lymphoma 2007;48(7):1290-8.
2007: Robert R McWilliams; Matthew P Goetz; Bruce W Morlan; Muhammad Salim; Kendrith M Rowland; James E Krook; Matthew M Ames; Charles Erlichman
Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer.
Clinical colorectal cancer 2007;6(7):516-21.
2007: Michael J Robertson; Brad S Kahl; Julie M Vose; Sven de Vos; Mary Laughlin; Patrick J Flynn; Kendrith M Rowland; Jose C Cruz; Stuart L Goldberg; Luna Musib; Christelle Darstein; Nathan Enas; Jeffery L Kutok; Jon C Aster; Donna Neuberg; Kerry J Savage; Ann S LaCasce; Donald Thornton; Christopher A Slapak; Margaret A Shipp
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1741-6.
2007: Aminah Jatoi; Patrick A Burch; David W Hillman; Joanne M Vanyo; Shaker R Dakhil; Daniel A Nikcevich; Kendrith M Rowland; Roscoe Morton; Patrick J Flynn; Charles Young; Winston Tan
A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.
Urology 2007;69(2):289-94.
2007: Ivana T Croghan; Richard D Hurt; Shaker R Dakhil; Gary A Croghan; Jeff A Sloan; Paul J Novotny; Kendrith M Rowland; Albert M Bernath; Mary L Loots; Nguyet A Le-Lindqwister; Loren K Tschetter; Stewart C Garneau; Kathleen A Flynn; Larry P Ebbert; Donald B Wender; Charles L Loprinzi
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
Mayo Clinic proceedings. Mayo Clinic 2007;82(2):186-95.
2006: Antonio Llombart-Cussac; Maria Theodoulou-Haber; Kendrith M Rowland; Romnee S Clark; Takashi Nakamura; Eva Carrasco; Giorgio Cruciani
Pemetrexed in patients with locally advanced or metastatic breast cancer who had received previous anthracycline and taxane treatment: phase II study.
Clinical breast cancer 2006;7(5):380-5.
2006: Michael J O'Connell; Daniel J Sargent; Harold E Windschitl; Lois Shepherd; Michelle R Mahoney; James E Krook; Sandra Rayson; Roscoe F Morton; Kendrith M Rowland; John W Kugler
Randomized clinical trial of high-dose levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk colon cancer.
Clinical colorectal cancer 2006;6(2):133-9.
2006: Aminah Jatoi; Shauna Hillman; Philip J Stella; Kendrith M Rowland; Roscoe Morton; Shaker R Dakhil
Why do oncologists prescribe--or not prescribe--conventional chemotherapy to geriatric patients with metastatic non-small cell lung cancer?
The journal of supportive oncology 2006;4(7):311-2.
2006: Matthew M Clark; Richard D Hurt; Ivana T Croghan; Christi A Patten; Paul J Novotny; Jeff A Sloan; Shaker R Dakhil; Gary A Croghan; Edward J Wos; Kendrith M Rowland; Albert M Bernath; Roscoe F Morton; Sachdex P Thomas; Loren K Tschetter; Stewart Garneau; Philip J Stella; Larry P Ebbert; Donald B Wender; Charles L Loprinzi
The prevalence of weight concerns in a smoking abstinence clinical trial.
Addictive behaviors 2006;31(7):1144-52.
2006: Barbara A Pockaj; James G Gallagher; Charles L Loprinzi; Philip J Stella; Debra L. Barton; Jeff A Sloan; Beth I Lavasseur; Radha M Rao; Tom R Fitch; Kendrith M Rowland; Paul J Novotny; Patrick J Flynn; Elliott Richelson; Abdul Fauq
Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2836-41.
2006: Julian R Molina; Daniel A Nikcevich; Shauna Hillman; Susan Geyer; Timothy Drevyanko; James Jett; Joseph Verdirame; Henry D Tazelaar; Kendrith M Rowland; Edward Wos; Leila Kutteh; Suresh Nair; Tom R Fitch; Patrick Flynn; Philip J Stella; Alex A. Adjei
A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer.
Cancer investigation 2006;24(4):382-9.
2006: Kostandinos Sideras; Paul L Schaefer; Scott H Okuno; Jeff A Sloan; Leila Kutteh; Tom R Fitch; Shaker R Dakhil; Ralph Levitt; Steven R Alberts; Roscoe F Morton; Kendrith M Rowland; Paul J Novotny; Charles L Loprinzi
Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial.
Mayo Clinic proceedings. Mayo Clinic 2006;81(6):758-67.
2006: M Baweja; Vera J Suman; Tom R Fitch; James A Mailliard; Albert M Bernath; Kendrith M Rowland; Steven R Alberts; J S Kaur; Edith A Perez
Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(4):623-9.
2006: Grace K Dy; James R Jett; Francois J Geoffroy; Keith D Krewer; Henry D Tazelaar; Matthew Maurer; Kendrith M Rowland; James A Mailliard; James E Krook; Shaker R Dakhil; Leila Kutteh; John Kugler; Donald B Wender
Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: phase II trial of the North Central Cancer Treatment Group.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(3):211-7.
2006: David P Steensma; Roy Molina; Jeff A Sloan; Daniel A Nikcevich; Paul L Schaefer; Kendrith M Rowland; Todor Dentchev; Paul J Novotny; Loren K Tschetter; Steven R Alberts; Thomas F Hogan; Amy Law; Charles L Loprinzi
Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1079-89.
2006: James N Ingle; Vera J Suman; Kendrith M Rowland; Deepu Mirchandani; Albert M Bernath; John K Camoriano; Paul A. Fishkin; Daniel A Nikcevich; Edith A Perez
Fulvestrant in women with advanced breast cancer after progression on prior aromatase inhibitor therapy: North Central Cancer Treatment Group Trial N0032.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1052-6.
2006: Harry J Long; Robert A Nelimark; Karl C Podratz; Vera J Suman; Gary L Keeney; Daniel A Nikcevich; John W Kugler; Kendrith M Rowland; Carl G Kardinal; Edward J Wos
Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
Gynecologic oncology 2006;100(3):501-5.
2006: Cynthia X Ma; P Steen; Kendrith M Rowland; R D Niedringhaus; Tom R Fitch; John W Kugler; David W Hillman; Edith A Perez; James N Ingle; Alex A. Adjei
A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(2):226-31.
2006: Aminah Jatoi; B R Murphy; Nathan R Foster; Daniel A Nikcevich; Steven R Alberts; James A Knost; Tom R Fitch; Kendrith M Rowland
Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(1):29-34.
2005: Steven R Alberts; William L Horvath; William C Sternfeld; Richard M Goldberg; Michelle R Mahoney; Shaker R Dakhil; Ralph Levitt; Kendrith M Rowland; Suresh Nair; Daniel J Sargent; John H Donohue
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9243-9.
2005: Edith A Perez; Vera J Suman; Kendrith M Rowland; James N Ingle; Muhammad Salim; Charles L Loprinzi; Patrick J Flynn; James A Mailliard; Carl G Kardinal; James E Krook; Abby R Thrower; Daniel W Visscher; Robert B Jenkins
Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252.
Clinical breast cancer 2005;6(5):425-32.
2005: Cynthia X Ma; Suresh Nair; Sachdev Thomas; Sumithra J Mandrekar; Daniel A Nikcevich; Kendrith M Rowland; Tom R Fitch; Harold E Windschitl; Shauna Hillman; Steven E Schild; James R Jett; Coleman K Obasaju; Alex A. Adjei
Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):5929-37.
2005: Charles L Loprinzi; Ralph Levitt; Debra L. Barton; Jeff A Sloan; Pamela J Atherton; Denise J Smith; Shaker R Dakhil; Dennis F Moore; James E Krook; Kendrith M Rowland; Miroslaw A Mazurczak; Alan R Berg; George P Kim
Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial.
Cancer 2005;104(1):176-82.
2005: Thomas E Witzig; Peter T Silberstein; Charles L Loprinzi; Jeff A Sloan; Paul J Novotny; James A Mailliard; Kendrith M Rowland; Steven R Alberts; James E Krook; Ralph Levitt; Roscoe F Morton
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2606-17.
2005: Patrick A Burch; James A Mailliard; David W Hillman; Edith A Perez; James E Krook; Kendrith M Rowland; Michael H Veeder; Michael W Cannon; James N Ingle
Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.
American journal of clinical oncology 2005;28(2):195-200.
2004: Steven R Alberts; Mark Schroeder; Charles Erlichman; Preston D Steen; Nathan R Foster; Dennis F Moore; Kendrith M Rowland; Suresh Nair; Loren K Tschetter; Tom R Fitch
Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(24):4944-50.
2004: William R Friedenberg; Martin S Tallman; Isadore Brodsky; Elisabeth Paietta; Jacob M Rowe; Sandra Lee; Kendrith M Rowland; George W Schnetzer; John C Reed
Modified VAD and PSC-833 in the treatment of resistant or relapsing chronic lymphocytic leukemia (E4996): a trial of the Eastern Cooperative Oncology Group.
Leukemia research 2004;28(8):813-9.
2004: Edith A Perez; David W Hillman; James A Mailliard; James N Ingle; J Michael Ryan; Tom R Fitch; Kendrith M Rowland; Carl G Kardinal; James E Krook; John W Kugler; Shaker R Dakhil
Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2849-55.
2004: Aminah Jatoi; Kendrith M Rowland; Charles L Loprinzi; Jeff A Sloan; Shaker R Dakhil; Neil MacDonald; Bruno Gagnon; Paul J Novotny; James A Mailliard; Teresita I L Bushey; Suresh Nair; Brad Christensen
An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2469-76.
2004: Anne Kanard; Aminah Jatoi; Rene Castillo; Susan Geyer; Thomas K Schulz; Tom R Fitch; Kendrith M Rowland; Suresh Nair; James E Krook; John W Kugler
Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity.
Lung cancer (Amsterdam, Netherlands) 2004;43(3):345-53.
2003: Aminah Jatoi; Neil Ellison; Patrick A Burch; Jeff A Sloan; Shaker R Dakhil; Paul J Novotny; Winston Tan; Tom R Fitch; Kendrith M Rowland; Charles Y F Young; Patrick J Flynn
A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.
Cancer 2003;97(6):1442-6.
2002: Svetomir Markovic; Vera J Suman; Robert J Dalton; John E Woods; Robert J Fitzgibbons; Lester E Wold; Jan C Buckner; John W Kugler; James A Mailliard; Kendrith M Rowland; James E Krook; David W Brown; Maria Tria Tirona; Edward T. Creagan
Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanoma.
American journal of clinical oncology 2002;25(6):552-6.
2002: Julie E Hammack; John C Michalak; Charles L Loprinzi; Jeff A Sloan; Paul J Novotny; Gamini S Soori; Maria Tria Tirona; Kendrith M Rowland; Philip J Stella; Joanne A Johnson
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy.
Pain 2002;98(1-2):195-203.
2002: Jeff A Sloan; Daniel J Sargent; Jed Lindman; Cristine Allmer; Delfino Vargas-Chanes; Edward T. Creagan; James A. Bonner; Michael J O'Connell; Robert J Dalton; Kendrith M Rowland; Burke J Brooks; John A Laurie
A new graphic for quality adjusted life years (Q-TWiST) survival analysis: the Q-TWiST plot.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2002;11(1):37-45.
2002: Aminah Jatoi; Maria Tria Tirona; Stephen S Cha; Steven R Alberts; Kendrith M Rowland; Roscoe F Morton; Suresh Nair; Carl G Kardinal; Philip J Stella; James A Mailliard; Daniel Sargen; Richard M Goldberg
A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia.
International journal of gastrointestinal cancer 2002;32(2-3):115-23.
1999: Charles L Loprinzi; John W Kugler; Jeff A Sloan; James A Mailliard; James E Krook; M B Wilwerding; Kendrith M Rowland; John K Camoriano; Paul J Novotny; Bradley J Christensen
Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3299-306.
1999: James A Martenson; Thomas G Shanahan; Michael J O'Connell; Charles D Cobau; Georgene Schroeder; Patrick A Burch; Ralph Levitt; Kendrith M Rowland
Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy.
Cancer 1999;86(4):710-4.
1999: Edward T. Creagan; Vera J Suman; R J Dalton; Henry C Pitot; Harry J Long; Michael H Veeder; Allen M Vukov; Kendrith M Rowland; James E Krook; John C Michalak
Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1884-90.
1998: Evanthia C Galanis; Jan C Buckner; Patrick A Burch; Paul L Schaefer; Robert P Dinapoli; Paul J Novotny; Bernd W Scheithauer; Kendrith M Rowland; Allen M Vukov; James A Mailliard; Roscoe F Morton
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):2953-8.
1997: Edward T. Creagan; Kendrith M Rowland; Vera J Suman; Carl G Kardinal; RF Marschke; Randolph S Marks; William J Maples
Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma.
American journal of clinical oncology 1997;20(5):490-2.
1997: Neil Ellison; Charles L Loprinzi; J Kugler; Alan K Hatfield; A Miser; Jeff A Sloan; Donald B Wender; Kendrith M Rowland; R Molina; Terrence L Cascino; Allen M Vukov; H S Dhaliwal; C Ghosh
Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2974-80.
1997: Charles L Loprinzi; Samir Abu-Ghazaleh; Jeff A Sloan; C vanHaelst-Pisani; A M Hammer; Kendrith M Rowland; M Law; Harold E Windschitl; J S Kaur; Neil Ellison
Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):969-73.
1996: Kendrith M Rowland; Charles L Loprinzi; Edward G Shaw; A W Maksymiuk; Steven A Kuross; S H Jung; John W Kugler; Loren K Tschetter; C Ghosh; Paul L Schaefer; D Owen; J H Washburn; T A Webb; James A Mailliard; James R Jett
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):135-41.
1994: Richard M Goldberg; Charles L Loprinzi; Judith R O'Fallon; Michael H Veeder; A W Miser; James A Mailliard; John C Michalak; A M Dose; Kendrith M Rowland; N L Burnham
Transdermal clonidine for ameliorating tamoxifen-induced hot flashes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):155-8.
1993: Edward G Shaw; W L McGinnis; James R Jett; J Q Su; A R Frank; James A Mailliard; R E Engel; M Wiesenfeld; Kendrith M Rowland
Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non-small-cell carcinoma of the lung.
Journal of the National Cancer Institute 1993;85(4):321-3.